Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
326.09
+11.13 (3.53%)
Nov 20, 2024, 4:00 PM EST - Market closed
Medpace Holdings Market Cap
Medpace Holdings has a market cap or net worth of $10.11 billion as of November 21, 2024. Its market cap has increased by 22.35% in one year.
Market Cap
10.11B
Enterprise Value
9.61B
1-Year Change
22.35%
Ranking
Category
Stock Price
$326.09
Market Cap Chart
Since August 11, 2016, Medpace Holdings's market cap has increased from $1.10B to $10.11B, an increase of 817.90%. That is a compound annual growth rate of 30.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 9.79B | 4.08% |
| Dec 29, 2023 | 9.41B | 42.38% |
| Dec 30, 2022 | 6.61B | -15.55% |
| Dec 31, 2021 | 7.82B | 57.08% |
| Dec 31, 2020 | 4.98B | 64.41% |
| Dec 31, 2019 | 3.03B | 60.71% |
| Dec 31, 2018 | 1.88B | 38.21% |
| Dec 29, 2017 | 1.36B | -7.16% |
| Dec 30, 2016 | 1.47B | 33.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Techne | 10.92B |
| Smith & Nephew | 10.74B |
| Vaxcyte | 10.71B |
| Catalent | 10.71B |
| Sarepta Therapeutics | 10.59B |
| Encompass Health | 9.97B |
| Exelixis | 9.90B |
| Exact Sciences | 9.75B |